JIM 2012
9th to 11th of February, Roma

HEXACATH will have the pleasure to welcome you at JIM 2012, International Meeting, Roma, Italy.

ASIA PCR 2012
12th to 14th of January, Singapore

HEXACATH will have the pleasure to welcome you at ASIA PCR 2012, in the International Convention & Exhibition Centre, Singapore.

TCT 2011
7th to 11th of November, San Francisco

HEXACATH will have the pleasure to welcome you at TCT 2011, in the Moscone Center, San Francisco, CA.

ESC Congess 2011
27th to 31th of August, Paris Nord Villepinte

HEXACATH will have the pleasure to welcome you at ESC Congress 2011 in Paris Nord Villepinte.

euroPCR 2011
17th to 20th of May, Paris

HEXACATH will have the pleasure to welcome you at euroPCR 2011 in Paris.

ICI meeting 2010
5th to 7th of December, Tel-Aviv.

HEXACATH will have the pleasure to welcome you at the ICI meeting 2010, David InterContinental Tel-Aviv, Israel.

Congrès Francophone
13th to 15th of October, Paris.

HEXACATH will have the pleasure to welcome you at the XIIe Paris Cardiovascular Interventions Course in the Hotel Meridien Etoile, Paris, France.

TCT 2010
21st to 25th of September, Washington, DC

From 21st to 25th of September 2010, HEXACATH will have the pleasure to welcome you at TCT 2010 in Washington, DC, USA.

ESC CONGRESS 2010
28th of August to 1st of September, Stockholm

From 28th of August to 1st of September 2010, HEXACATH will have the pleasure to welcome you at ESC CONGRESS 2010 in Stockholm, Sweden.

euroPCR 2010
25th to 28th of May, Paris

HEXACATH will have the pleasure to welcome you at euroPCR 2010 in Paris.
Come and visit us booth #9 - #10.

JIM 2010
11th to 33th of February, Rome

HEXACATH will have the pleasure to welcome you at JIM 2010 in Rome.
You can attend the Hexacath Symposium:
TiTAN2 Bio Active Stent long term follow up: 3 and 5 years.
Speaker: Pasi Karjalainen

ASIA PCR 2010
21st to 23rd of January, Singapore

HEXACATH will have the pleasure to welcome you at ASIA PCR 2010 in Singapore.
You can attend the Hexacath Symposium:
Bio Active Stents (B.A.S) coated with Titanium Nitride Oxide: The Only Safe Approach to Restenosis Reduction.
Goal: To review the data about the efficacy of the Titanium-NO coated stent, to understand the long term patient benefit with B.A.S requiring only short term dual antiplatelet treatment, to share the latest TITAN2 clinical data in various population subsets such as ACS, Small Vessels and all comers.

ICI 2009
December 6-8, 2009, Tel-Aviv

Innovations in Cardiovascular Interventions.
HEXACATH will have the pleasure to welcome you at ICI 2009, Hotel David InterContinental Tel-Aviv, Israel.

Monday, December 07, 2009:
11:30 - 13:00 S4 - The Future of Bioactive and Drug Eluting Stents (Cont.)
12:30 Drug Eluting Balloon - Leonhard Bruch, Germany
12:42 TITAN II Bio-Active Stent in Acute Coronary Syndrome - Otto Hess, Switzerland

Tuesday, December 08, 2009:
08:30 - 10:30 S15 - Stents, Drugs and Beyond (Cont.)
10:18 TITAN 2 Bio-Active Stent Long Term Follow Up: 3 and 5 Years - Pasi Karjalainen, Finland

GISE 2009
20th to 23rd of October, Bologne

XXX Congresso Nazionale della Società Italiana di Cardiologia Invasiva. HEXACATH will have the pleasure to welcome you at GISE 2009, Palazzo della Cultura e dei Congressi, Bologna, Italy.

TEAM 2009
14th to 16th of October, Madrid

VII International Course of Endovascular and Miocardial Therapy. HEXACATH will have the pleasure to welcome you at TEAM 2009, Hotel Melia Castilla, Madrid, Spain.
You can attend the Symposium Hexacath Sala Patio, the 15th of October.
Speaker #1: Dr Anti Ylitalo - TITAX AMI, a 3-year Follow up.
Speaker #2: Pr Hess - DES in AMI: a risky choice?
Moderators: Dr Antonio Serra, Dr Eberhard Grube.

Congrès Francophone
14th to 16th of October, Paris.

HEXACATH will have the pleasure to welcome you at the XIe Paris Cardiovascular Interventions Course in the Hotel Meridien Etoile, Paris, France.

TCT 2009
23th to 25th of September, San Francisco.

HEXACATH will have the pleasure to welcome you at TCT 2009 in the Moscone Center, San Francisco, USA. Booth #2029.
You can also attend the Symposium "Bio Active Stents: The New Approach to Combine Efficacy and Safety Over Time", Thursday 24th - 7h00, Room #124. Faculty: Otto M. Hess, MD, Pasi Karjalainen, MD and Michael Angioi, MD.

NEW HEXACATH WEB SITE
1st of September

The new Hexacath web site is on line since the 1st of september. New design, new functionnalities, we hope you'll enjoy it.

ESC CONGRESS 2009
29th of August to 2nd of September, Barcelona

HEXACATH will have the pleasure to welcome you at ESC Congress in Barcelona, Spain. Booth #K505.

EUROPCR
19th to 22nd of May, Barcelona

From the 19th to the 22nd of May, Hexacath is pleased to welcome you at Booth #04 at the entrance of the main exhibit hall. Don't miss the Hexacath Symposium wednesday the 20th between 12:00 and 13:30 in Room 2 where the latest scientific clinical data about Bio Active Stents will be discussed by a panel of distinguished international experts. We are also pleased to inform you that a lecture about the 3-years follow up of the randomized study RIO will be presented in Room 124-125 wednesday the 20th between 08:30 and 10:00 AM.

JIM
14th to 16th of February, Rome

From the 14th to the 16th of February Hexacath was present during the JIM meeting hold in Rome, Italy. The JIM is an international congress organized by prestigious doctors such as Dr Antonio Colombo, Dr Eberhard Grube, Dr Martin Leon, Dr Jeffrey Moses and Dr Carlo Di Mario. The new Hexacath Italy team was also there to present the latest Hexacath products to roughly 1000 attendees coming from Italy and abroad. Noteworthy, invasive cardiologists have been able to attend the NEW CLASS OF STENTS Symposium in room Cicerone friday the 13th where Pr Otto Hess from the Bern University Hospital gave a lecture about the latest clinical data on the TITAN2 Bio Active Stent. The Symposium was chaired by Pr Antoniucci and Pr Mendiz.

ICI
7th to 9th of December, Tel Aviv

From the 7th to the 9th of December 2008, Hexacath was present at the ICI meeting in Tel Aviv. Hexacath had two major lectures: TITAX (Titanium-Nitride-Oxide coated stent versus Paclitaxel Eluting Stent) randomized study at 24 months of follow up presented by Dr Karjalainen from Pori, Finland, during a session chaired by Pr Gregg Stone, Dr Ran Kornowski and Dr Dan Tzivoni, and TINOX 5 years (Titnium-Nitride-Oxide coated stent versus Bare Metal Stent) presented by Pr O.Hess from Bern, Switzerland, chaired by Dr Nicholas Kipshide, Dr Basil Lewis and Dr Ali Oto.

TEAM
19th to 21st of November, Madrid

From the 19th to the 21st of November, Hexacath was present at the TEAM congress in Madrid, Spain.

TCT
14th to 16th of October, Washington

From the 14th to the 16th of October 2008, Hexacath was present at the TCT congress in Washington, USA, where the company hold a Breakfast Meeting Symposium in which Hexacath had two major lectures:
Pr O.Hess from the Bern Univeristy Hospital Switzerland presented the 5-year follow of the randomized study TINOX comparing Titanium-Nitride-Oxide coated stents versus uncoated bare metal stents, and Dr P.Karjalainen from the Pori Central Hospital Finland presented the 18-month results of the TITAX randomized study comparing the Titanium-Nitride-Oxide coated stent versus the Paclitaxel Eluting Stent.